Matt Sutherland is a solo angel investor with experience in biotools commercialization and intellectual property strategy. He focuses on investing in life sciences tools, services, and biopharma services companies, particularly those in the commercial and pre-commercial stages with a proven market need.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions